Cargando…
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression
As a hallmark of metabolic reprogramming, aerobic glycolysis contributes to tumorigenesis and aggressiveness. However, the mechanisms and therapeutic strategies regulating aerobic glycolysis in neuroblastoma (NB), one of leading causes of cancer-related death in childhood, still remain elusive. Meth...
Autores principales: | Fang, Erhu, Wang, Xiaojing, Wang, Jianqun, Hu, Anpei, Song, Huajie, Yang, Feng, Li, Dan, Xiao, Wenjing, Chen, Yajun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993229/ https://www.ncbi.nlm.nih.gov/pubmed/32042322 http://dx.doi.org/10.7150/thno.37383 |
Ejemplares similares
-
Therapeutic Targeting of MZF1‐AS1/PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression
por: Fang, Erhu, et al.
Publicado: (2019) -
RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
por: Song, Huajie, et al.
Publicado: (2020) -
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
por: Song, Huajie, et al.
Publicado: (2023) -
Therapeutic targeting of circ‐CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression
por: Li, Huanhuan, et al.
Publicado: (2019) -
The Mutational Landscape of the Oncogenic MZF1 SCAN Domain in Cancer
por: Nygaard, Mads, et al.
Publicado: (2016)